Priority Date: 09.08.12 (IT 2012RM00405)

COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS THAT ARE AMELIORATED BY INHIBITION OF HDAC

  • Application ID: EP13745671
  • Status: The patent has been granted

Attorney

operating since 2002
Headquarter in Rome
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 09.08.2012 - Priority Date (IT 2012RM00405)
  • 13.02.2014 - Publication A1 (WO2014023754)
  • 17.06.2015 - Publication A1 (EP2882724)
  • 01.11.2017 - Publication B1 (EP2882724)